Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
2003 2
2009 1
2010 1
2012 3
2013 2
2014 1
2016 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Short-term and long-term effects of tibolone in postmenopausal women.
Formoso G, Perrone E, Maltoni S, Balduzzi S, Wilkinson J, Basevi V, Marata AM, Magrini N, D'Amico R, Bassi C, Maestri E. Formoso G, et al. Among authors: magrini n. Cochrane Database Syst Rev. 2016 Oct 12;10(10):CD008536. doi: 10.1002/14651858.CD008536.pub3. Cochrane Database Syst Rev. 2016. PMID: 27733017 Free PMC article. Review.
BACKGROUND: Tibolone is a synthetic steroid used for the treatment of menopausal symptoms, on the basis of short-term data suggesting its efficacy. We considered the balance between the benefits and risks of tibolone. ...No evidence indicates that tibolone increases the ri …
BACKGROUND: Tibolone is a synthetic steroid used for the treatment of menopausal symptoms, on the basis of short-term data suggesting …
Short and long term effects of tibolone in postmenopausal women.
Formoso G, Perrone E, Maltoni S, Balduzzi S, D'Amico R, Bassi C, Basevi V, Marata AM, Magrini N, Maestri E. Formoso G, et al. Among authors: magrini n. Cochrane Database Syst Rev. 2012 Feb 15;(2):CD008536. doi: 10.1002/14651858.CD008536.pub2. Cochrane Database Syst Rev. 2012. PMID: 22336846 Updated. Review.
BACKGROUND: Tibolone is an option available for the treatment of menopausal symptoms, based on short-term data on its efficacy. However, there is a need to consider the balance between the benefits and risks of tibolone as there are concerns about breast and endometrial ca …
BACKGROUND: Tibolone is an option available for the treatment of menopausal symptoms, based on short-term data on its efficacy. Howev …
Informing women about hormone replacement therapy: the consensus conference statement.
Mosconi P, Donati S, Colombo C, Mele A, Liberati A, Satolli R; Consensus Conference Working Group. Mosconi P, et al. BMC Womens Health. 2009 May 29;9:14. doi: 10.1186/1472-6874-9-14. BMC Womens Health. 2009. PMID: 19480688 Free PMC article.
RESULTS: Key messages in the CC's deliberation were: a) women need to be fully informed about the transient nature of menopausal symptoms, about HRT risks and benefits and about the availability of non-pharmacological interventions; b) HRT is not recommended to prevent menopausal …
RESULTS: Key messages in the CC's deliberation were: a) women need to be fully informed about the transient nature of menopausal symptoms, a …
Overview of randomized clinical trials of oral branched-chain amino acid treatment in chronic hepatic encephalopathy.
Fabbri A, Magrini N, Bianchi G, Zoli M, Marchesini G. Fabbri A, et al. Among authors: magrini n. JPEN J Parenter Enteral Nutr. 1996 Mar-Apr;20(2):159-64. doi: 10.1177/0148607196020002159. JPEN J Parenter Enteral Nutr. 1996. PMID: 8676537 Review.
Their quality score was much better than that of the remaining seven negative small studies, carrying a significant risk of type II error. CONCLUSIONS: Based on the results of the two largest, long-term studies, the use of oral branched-chain amino acids in the prevention …
Their quality score was much better than that of the remaining seven negative small studies, carrying a significant risk of type II error. C …
Long term effectiveness on prescribing of two multifaceted educational interventions: results of two large scale randomized cluster trials.
Magrini N, Formoso G, Capelli O, Maestri E, Nonino F, Paltrinieri B, Del Giovane C, Voci C, Magnano L, Daya L, Marata AM; INDRA-NET study group. Magrini N, et al. PLoS One. 2014 Oct 17;9(10):e109915. doi: 10.1371/journal.pone.0109915. eCollection 2014. PLoS One. 2014. PMID: 25329386 Free PMC article. Clinical Trial.
Outreach visits promoting independent information have proved moderately effective in changing prescribing behaviours. OBJECTIVES: Testing the short and long-term effectiveness on general practitioners' prescribing of small groups meetings led by pharmacists. ...INTERPRETA …
Outreach visits promoting independent information have proved moderately effective in changing prescribing behaviours. OBJECTIVES: Testing t …
A population based cohort study to assess the safety of pandemic influenza vaccine Focetria in Emilia-Romagna region, Italy - part two.
Moro ML, Nobilio L, Voci C, Di Mario S, Candela S, Magrini N; SaFoH1N1 working group. Moro ML, et al. Among authors: magrini n. Vaccine. 2013 Feb 27;31(10):1438-46. doi: 10.1016/j.vaccine.2012.07.090. Epub 2012 Aug 10. Vaccine. 2013. PMID: 22885015
Most frequent short-term incident AESIs were convulsions (4 out of 11), and demyelinating diseases (3 out of 11). ...Most common long-term incident AESIs were demyelinating diseases (21 out of 60), and vasculitis (13 out of 60). ...
Most frequent short-term incident AESIs were convulsions (4 out of 11), and demyelinating diseases (3 out of 11). ...Most common long …
Changes in long-term glycemic control and performance indicators in a cohort of type 2 diabetic patients cared for by general practitioners: findings from the "Modena Diabetes Project".
Ciardullo AV, Daghio MM, Brunetti M, Bevini M, Daya G, Feltri G, Novi D, Goldoni CA, Messori A, Guerzoni A, Magrini N. Ciardullo AV, et al. Among authors: magrini n. Nutr Metab Cardiovasc Dis. 2003 Dec;13(6):372-6. doi: 10.1016/s0939-4753(03)80006-6. Nutr Metab Cardiovasc Dis. 2003. PMID: 14979684
Furthermore, the percentages of performance indicators matching the expected rate of recurrence per each year of follow-up significantly improved during the study period. CONCLUSIONS: Long-term glycemic control and the performance indicators relating to the type 2 diabetic …
Furthermore, the percentages of performance indicators matching the expected rate of recurrence per each year of follow-up significantly imp …
Management of supratentorial epidural hematoma in children: report on 49 patients.
Paiva WS, Andrade AF, Mathias Júnior L, Guirado VM, Amorim RL, Magrini NN, Teixeira MJ. Paiva WS, et al. Among authors: magrini nn. Arq Neuropsiquiatr. 2010 Dec;68(6):888-92. doi: 10.1590/s0004-282x2010000600011. Arq Neuropsiquiatr. 2010. PMID: 21243247 Free article.
In this study, we present the results from a sample of patients with EDH with long-term follow-up. METHOD: Between January 2006 and December 2008, 49 patients with traumatic EDH were treated at our unit. ...
In this study, we present the results from a sample of patients with EDH with long-term follow-up. METHOD: Between January 2006 and D …
An early (3-6 weeks) active surveillance study to assess the safety of pandemic influenza vaccine Focetria in a province of Emilia-Romagna region, Italy - part one.
Candela S, Pergolizzi S, Ragni P, Cavuto S, Nobilio L, Di Mario S, Dragosevic V, Groth N, Magrini N; SaFoH1N1 working group. Candela S, et al. Among authors: magrini n. Vaccine. 2013 Feb 27;31(10):1431-7. doi: 10.1016/j.vaccine.2012.06.030. Epub 2012 Jul 2. Vaccine. 2013. PMID: 22766247
INTRODUCTION: An observational, non-comparative, prospective, surveillance study of individuals vaccinated with the MF59-adjuvanted A/H1N1 influenza vaccine, Focetria, (Novartis Vaccines & Diagnostics, Siena, Italy), was performed in Italy during the 2009 A/H1N1 influenza pan …
INTRODUCTION: An observational, non-comparative, prospective, surveillance study of individuals vaccinated with the MF59-adjuvanted A/H1N1 i …
Use of benzodiazepines in the Italian general population: prevalence, pattern of use and risk factors for use.
Magrini N, Vaccheri A, Parma E, D'Alessandro R, Bottoni A, Occhionero M, Montanaro N. Magrini N, et al. Eur J Clin Pharmacol. 1996;50(1-2):19-25. doi: 10.1007/s002280050063. Eur J Clin Pharmacol. 1996. PMID: 8739806
The average daily dose taken was relatively low: 61% of short-term users and 51% of chronic users used less than half a defined daily dose (DDD). ...
The average daily dose taken was relatively low: 61% of short-term users and 51% of chronic users used less than half a defined daily …
11 results